BMS/Bluebird Ready Abecma, First BCMA-Targeting CAR-T, For Initial Patients

REMS-Required Training And Certification Under Way

Man in red shirt preparing for stair run
BMS and bluebird won the race to bring a BCMA-targeting CAR-T to market, but the climb to commercial success begins now • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip